Alliance for Regenerative Medicine CELL & GENE Meeting On The Med 2025

Alliance for Regenerative Medicine CELL & GENE Meeting On The Med 2025

$65

Categories: - MedS, Alliance for Regenerative Medicine (Meeting on the med CME), Hematology, Internal Medicine, Oncology Tags: advanced therapy clinical development, advanced therapy clinical trials, advanced therapy collaborative sessions, advanced therapy commercialization, advanced therapy conference videos, advanced therapy financing, advanced therapy global adoption, advanced therapy global impact, advanced therapy hybrid event, advanced therapy industry challenges, advanced therapy industry insights, advanced therapy industry networking, advanced therapy innovation, advanced therapy investment insights, advanced therapy manufacturing, advanced therapy market trends, advanced therapy networking, advanced therapy partnering, advanced therapy quality control, advanced therapy regulatory updates, advanced therapy stakeholders, advanced therapy strategic insights, advanced therapy supply chain, Alliance for Regenerative Medicine, Alliance for Regenerative Medicine event, ARM advanced therapies, ARM biotech conference, ARM Cell & Gene Meeting, ARM cell gene therapy, ARM cell gene therapy event, ARM conference 2025, ARM Europe event, ARM event Rome, ARM hybrid conference, ARM industry networking, ARM Meeting on the Med, ARM Meeting on the Med 2025, ARM regenerative medicine conference, biotech commercialization Europe, biotech commercialization strategies, biotech conference April 2025, biotech conference recordings, biotech entrepreneurs conference, biotech executive education, biotech fundraising strategies, biotech industry event, biotech industry leaders, biotech industry networking, biotech industry workshops, biotech innovation conferences, biotech innovation strategies, biotech investment strategies, biotech investor networking, biotech partnering opportunities, biotech regulatory compliance, biotechnology conference Europe, biotechnology fundraising, cell and gene therapy conference, cell gene therapy best practices, cell gene therapy clinical trials, cell gene therapy commercialization, cell gene therapy company presentations, cell gene therapy conference 2025, cell gene therapy conference content, cell gene therapy conference Europe, cell gene therapy conference hybrid, cell gene therapy conference Italy, cell gene therapy conference lectures, cell gene therapy conference Mediterranean, cell gene therapy conference networking, cell gene therapy conference panels, cell gene therapy conference pdf, cell gene therapy conference presentations, cell gene therapy conference Rome, cell gene therapy conference sessions, cell gene therapy conference workshops, cell gene therapy educational content, cell gene therapy event 2025, cell gene therapy event highlights, cell gene therapy event program, cell gene therapy expert panels, cell gene therapy financing, cell gene therapy fireside chats, cell gene therapy fundraising, cell gene therapy hybrid format, cell gene therapy immersive learning, cell gene therapy industry panels, cell gene therapy investment, cell gene therapy investors, cell gene therapy learning, cell gene therapy lifecycle, cell gene therapy market trends, cell gene therapy networking, cell gene therapy patient advocates, cell gene therapy PDF resources, cell gene therapy presentations, cell gene therapy professionals, cell gene therapy program, cell gene therapy public-private partnerships, cell gene therapy Rome, cell gene therapy Rome Cavalieri, cell gene therapy strategic insights, cell gene therapy supply chain logistics, cell gene therapy video lectures, cell gene therapy workshop, cell gene therapy workshops, cell therapy manufacturing, cell therapy regulatory frameworks, clinical development cell gene therapy, commercialization advanced therapies, European cell gene therapy, fireside chats biotech, gene therapy manufacturing, gene therapy regulatory frameworks, global adoption advanced therapies, Hematology / Oncology, hybrid medical conference, hybrid medical conferences, in-person biotech conference, in-person biotech events, manufacturing experts advanced therapies, manufacturing experts cell gene therapy, manufacturing scale-up advanced therapies, manufacturing scale-up cell gene, market access advanced therapies, Medical Conference 2025, medical innovation conference, Meeting on the Mediterranean, Meeting on the Mediterranean 2025, Pathology courses, patient advocates regenerative medicine, public-private partnerships biotech, quality assurance advanced therapies, quality assurance cell gene therapy, regenerative medicine conference, regenerative medicine event, regenerative medicine industry trends, regenerative medicine networking, regulatory professionals advanced therapies, regulatory strategies cell gene therapy, researchers cell gene therapy, Rome biotech conference, Rome medical conference 2025, therapy lifecycle management, therapy market access challenges, virtual medical partnering Brand: MedBoardCourses

Description

Include: 5 videos + 1 pdf, size: 76.68 GB

Target Audience: researchers, biotech entrepreneurs

Information:

The Cell & Gene Meeting on the Mediterranean (Meeting on the Med) 2025, organized by the Alliance for Regenerative Medicine, is Europe’s foremost conference for advanced therapy stakeholders. This hybrid event brings together leading companies, investors, regulators, and researchers in the cell and gene therapy sector to explore commercialization, manufacturing, regulatory frameworks, and financing of next-generation treatments.

What You Will Learn

Key challenges and opportunities in bringing cell and gene therapies to market—including regulatory strategies, market access, and clinical development
Best practices in manufacturing scale-up, quality assurance, and supply chain logistics specific to advanced therapies
Financial and investment insights tailored to advanced biotechnology companies navigating fundraising and public-private partnerships
Firsthand lessons from company presentations, industry panels, and thought-leader insights across different stages of the therapy lifecycle

Event Details

Event: ARM Cell & Gene Meeting on the Mediterranean 2025
Dates: April 15–17, 2025 (in-person); April 21–22, 2025 (virtual partnering access)
Location: Rome Cavalieri, Rome, Italy
Format: Hybrid delivery combining live in-person sessions, one-on-one partnering, interactive workshops, and virtual streaming
Highlights:
- Over 50 corporate presentations
- Extensive partnering opportunities (1000+ one-on-one meetings)
- Expert-led panels and fireside chats
- Networking receptions and collaborative industry sessions

Who Should Attend
Executives, researchers, biotech entrepreneurs, investors, regulators, manufacturing experts, and patient advocates engaged in the cell and gene therapy ecosystem—especially those seeking to accelerate commercialization and global adoption of advanced therapies.

Why Attend
This event unites the most relevant commercial, scientific, and regulatory perspectives in one of biotechnology’s fastest-moving fields. Participants gain invaluable connections, practical insight into industry challenges, and a strategic edge in positioning their innovations for global impact—all within an immersive, hybrid learning format.

+ Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

Apirl 15 Salone dei Cavalieri, Section 2.mp4
Apirl 15 Salone dei Cavalieri, Section 3&4.mp4
Apirl 16 Salone dei Cavalieri, Section 2.mp4
Apirl 16 Salone dei Cavalieri, Section 3&4.mp4
Apirl 17 Salone dei Cavalieri, Section 3&4.mp4
CGMED-Event-Program-2025-Digital-Final-2.pdf